Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

LI-COR Biosciences Inc.

www.licor.com

Latest From LI-COR Biosciences Inc.

Finance Watch: Former Juno Execs Launch Sana With Allogeneic Cell Therapy Platform

Private Company Edition: Former Juno execs launch allogeneic cell therapy venture Sana, Atlas raises a $250m fund, and the Rakuten Aspyrian, Apollomics and Antengene VC deals exceed the $100m mark.

Financing StartUps and SMEs

Finance Watch: Rakuten Aspyrian Raises $150m VC Round For Laser-Activated Cancer Drugs

Private investors, including Japanese e-commerce mogul Hiroshi Mikitani, backed a $150m Series C round for Rakuten Aspyrian and its photoimmunotherapy platform. Also, pharma-backed therapeutic video game developer Akili boosts Series C to $68m, and Summit garners additional BARDA funding.

Financing Business Strategies

Finance Watch: Happy Holidays For Flagship With A New $618m Fund

Private Company Edition: Flagship ends 2017 with its biggest life science fund yet totaling $618m. Also, December sees a year-end surge in VC deals, including a $100m Series B round for Allakos.

Financing StartUps and SMEs

Perkin-Elmer Eyes the Value Chain

Perkin-Elmer built the machines that enabled the boom in genomics research--automated DNA sequencers. Genomics companies have done well, but Perkin-Elmer hasn't. The company is prepared to spend up to $1 billion over the next several years on external collaborations and acquisitions in an effort to climb the value chain and capture high-value applications of its tools for itself.
BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Li-Cor Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • LI-COR Biosciences Inc.
  • Senior Management
  • Contact Info
  • LI-COR Biosciences Inc.
    Phone: (402) 467-3576
    4647 Superior St.
    Lincoln, NE 68504
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register